CHINA Smooth production and sufficient capacity for China's homegrown COVID vaccines: Ministry

CHINA

Smooth production and sufficient capacity for China's homegrown COVID vaccines: Ministry

Global Times

18:17, March 15, 2021

A staff member carries containers of the COVID-19 vaccine from the Chinese pharmaceutical company Sinovac at the Mexico City's international airport in Mexico, March 13, 2021. The third shipment of the COVID-19 vaccine from the Chinese pharmaceutical company Sinovac arrived Saturday at the Mexico City's international airport. (Photo:Xinhua)

China's current production of the four domestically developed COVID-19 vaccines in use in China can meet the combined demand of domestic inoculation, foreign aid and exports, a senior official with the Ministry of Industry and Information Technology (MIIT) said on Monday.

China's vaccine production has successfully met the demand of inoculation program of 64.98 million doses while at the same time supplied foreign aid and exports, Tian Yulong, senior official with MIIT, said at a State Council Information Office press conference.

Chinese has provided domestically developed vaccines to over 50 countries and exported vaccines to 27 countries, according to information released by the Foreign Ministry in end February.

Chinese vaccine companies are ramping up production capacity and has set up a dynamic mechanism to ensure supply cover demand, which will be meticulously measured and monitored, Tian said. "We are confident that output and production capacity of vaccines in every phase on the year could meet demand, blessed by China's industrial capability, corporate sector efficiency and adaptability to emergency."

Tian added the safety of vaccines, from production to transportation to inoculation, will be the top priority.

China also can ensure the smooth and systematic operation of the entire supply chain for vaccine production, including supplying the necessary raw materials, cold-chain logistics and equipment for administrating the shots.

The supply of such materials are ample and is able to support large-scale production of vaccines at the current moment and the foreseeable future, Tian said.

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue